From 2014 to 2016, New York’s Medicaid program saw a surge in drug spending that Governor Andrew Cuomo blamed on “abusive” behavior by drug manufacturers. But a new Empire Center issue brief shows that, after accounting for rebates, the surge was smaller than Cuomo described, and that it was mostly driven by enrollment growth. Overall, the report finds that price increases accounted for about one-fifth of the spending surge, while enrollment accounted for four-fifths.

After the Affordable Care Act took full effect in 2014, New York’s Medicaid enrollment grew by 1.3 million, or 28 percent, in large part due to the structure of the new health care law. The ACA broadened New York’s al­ready expansive Medicaid eligibility guide­lines, financed the hiring of “navigators” to facilitate sign-ups, threatened a tax pen­alty on those who failed to enroll and used marketing and media attention to increase public visibility.

When adjusted for enrollment and utilization, Medicaid’s drug costs over the past decade have been relatively well controlled compared to both national averages and recent history. Though costs have trended up since their 2013 low point, the program’s cost per prescription was lower in 2017 than when Cuomo took office.

The brief further shows that total drug costs are disproportionately driven by a small number of high-priced, brand-name medications. The top 10 costliest medications, out of more than 3,000 purchased, have accounted for 17 to 24 percent of total Medicaid drug costs in recent years. A handful of newly introduced hepatitis C drugs have been an especially big expense for New York since 2013, in part because officials were slow to restrict coverage.

The Empire Center, based in Albany, is an independent, not-for-profit, non-partisan think tank dedicated to promoting policies that can make New York a better place to live, work and raise a family.

You may also like

Hammond Submits Comments on Proposed Regulations for Pharmacy Benefit Managers

State regulators should drop plans to mandate a $10.18 "dispensing fee" for each prescription filled by a pharmacy, the Empire Center's Bill Hammond said in comments submitted Monday to the Department of Financial Services. Read More

Hammond Warns of Imminent Medicaid “Iceberg” in Legislative Testimony 

New York’s Medicaid program is currently on a crash course for fiscal disaster in the near future, warns Bill Hammond. Read More

State Budget Proposal Doubles Down on Reckless Spending, Empire Center Says

After Governor Hochul’s budget unveiling this afternoon, Empire Center experts offered their reactions to the latest framework. Read More

Personal Care Spending Eight Times Higher in New York Than National Average, New Report Shows

New York’s Medicaid program spends roughly $12 billion per year on in-home “personal care” for the elderly and disabled. Read More

Spend, Spend, Spend: Empire Center Weighs in on New York State Budget 

After nearly a week’s delay, Governor Kathy Hochul has finally announced a budget deal. Though the legislature has yet to formally agree to most of it, she disclosed numerous specifics of the purported $220 billion deal. Read More

Budget Testimony: Dangerous Misplaced Priorities on Health Care

In his spoken testimony, Hammond had intended to highlight key shortcomings of the governor's budget, including its lack of a plan to investigate the state's pandemic response Read More

Budget 2022: New revenue fuels spending surge

The Empire Center for Public Policy offered the following reactions to the proposed 2022 State Budget. Read More

State of the State Reactions: Will This Bring New Yorkers Back?

The Empire Center for Public Policy offered the following reactions to Governor Hochul’s first State of the State address. Read More